This grant is for establishing a critical immunologic reagent resource to enhance the optimal use of nonhuman primate (NHP) models in vaccine, adjuvant, transplantation, and infectious/immune-mediated disease research. The initiative will identify, develop, characterize, produce, and distribute essential immunologic reagents not readily available or optimized for NHP studies to the broader scientific community. Furthermore, it will create a comprehensive public website featuring a searchable database of both commercial and non-commercial immunologic reagents that cross-react with NHP cells or proteins. The tools and resources generated through this funding will significantly enable and accelerate NHP-based research, fostering breakthroughs in cures, vaccines, and treatments for complex immune-mediated and emerging infectious diseases.
Opportunity ID: 327921
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-20-043 |
| Funding Opportunity Title: | Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 29, 2020 |
| Last Updated Date: | Jun 29, 2020 |
| Original Closing Date for Applications: | Nov 19, 2020 |
| Current Closing Date for Applications: | Nov 19, 2020 |
| Archive Date: | Dec 25, 2020 |
| Estimated Total Program Funding: | $1,775,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Public and State controlled institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits applications for an immunologic reagent resource to support and facilitate the optimal use of nonhuman primate (NHP) models for vaccine and adjuvant development, transplantation, and infectious and immune-mediated diseases. This resource will identify, obtain, develop, characterize, evaluate, produce, and distribute to the scientific community key immunologic reagents for NHP research that are not commercially available or, if commercially available, are not optimized for use in NHPs. In addition, the resource will develop and provide a public website that includes a searchable database of information about immunologic reagents, commercial and non-commercial, that cross-react with NHP cells or proteins. The research tools generated and provided through this initiative will enable and accelerate NHP research on cures, vaccines, and treatments for immune-mediated diseases and emerging and reemerging infectious diseases. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-043.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00262386 | Oct 19, 2020 | Nov 19, 2020 | View |
Package 1
Mandatory forms
327921 RR_SF424_2_0-2.0.pdf
327921 PHS398_CoverPageSupplement_5_0-5.0.pdf
327921 RR_OtherProjectInfo_1_4-1.4.pdf
327921 PerformanceSite_2_0-2.0.pdf
327921 RR_KeyPersonExpanded_2_0-2.0.pdf
327921 RR_Budget_1_4-1.4.pdf
327921 PHS398_ResearchPlan_4_0-4.0.pdf
327921 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327921 RR_SubawardBudget30_1_4-1.4.pdf
327921 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
